StonvexLoading…
StonvexStonvexStonvexCore line items from CHTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $889.00M | $941.00M | $993.00M | $1.10B |
Operating Income | $12.91B | $13.12B | $12.56B | $11.96B |
Net Income | $4.99B | $5.08B | $4.56B | $5.05B |
EPS (Diluted) | $36.21 | $34.97 | $29.99 | $30.74 |
Total Assets | $154.21B | $150.02B | $147.19B | $144.52B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $477.00M | $459.00M | $709.00M | $645.00M |
Free Cash Flow OCF − CapEx | $4.42B | $3.16B | $3.32B | $5.55B |
Shares Outstanding | 137.74M | 145.36M | 151.97M | 164.43M |